Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 3/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | KIT | P10721 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | USP2 | O75604 | 4/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CASP1 | P29466 | 3/20 | 0.43 |
| ▸ | CASP7 | P55210 | 3/20 | 0.43 |
| ▸ | HBB | P68871 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | APP | P05067 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1695271 | 0.79 | HRH3 (0.60) | SLC6A2HRH3 | |
| SCHEMBL21321494 | 0.77 | LMNA (0.55) | HTR1AADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL1695428 | 0.76 | APP (0.64) | HTR1AADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL1695452 | 0.75 | CHRM2 (0.43) | HTR1AADRA1DLMNAHSD17B10APP | |
| SCHEMBL3454269 | 0.75 | CHRM2 (0.43) | ADRA1DKITLMNAHSD17B10APP | |
| SCHEMBL3454549 | 0.75 | KCNH2 (0.60) | HTR1AADRA1DLMNACYP3A4HSD17B10 | |
| SCHEMBL1695377 | 0.72 | HRH3 (0.54) | ADRA1DLMNACHRM2CHRM4CHRM5 | |
| Hydrochloric Acid SCHEMBL29641695 | 0.71 | HTR1A (0.65) | HTR1AADRA1DADRA1AADRA1BKIT | |
| SCHEMBL13740603 | 0.71 | USP2 (0.62) | HTR1AADRA1DLMNAUSP2TP53 | |
| SCHEMBL1695430 | 0.70 | MTNR1A (0.44) | HTR1AADRA1DADRA1AADRA1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023043953-A1 | COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | AVIDITY BIOSCIENCES, INC. (US) | 2023-03-23 | — | — | WO | disclosed |
| EP-4126066-A1 | COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY | Avidity Biosciences, Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| EP-4121063-A1 | COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | Avidity Biosciences, Inc. (US) | 2023-01-25 | — | — | EP | disclosed |
| EP-3898693-A1 | ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND USES THEREOF | Avidity Biosciences, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| WO-2021195469-A1 | COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY | AVIDITY BIOSCIENCES, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| WO-2021188390-A1 | COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | AVIDITY BIOSCIENCES, INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| EP-3735252-A2 | HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF | Avidity Biosciences, Inc. (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-3720448-A1 | COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY | Avidity Biosciences, Inc. (US) | 2020-10-14 | — | — | EP | disclosed |
| EP-3691657-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | Avidity Biosciences, Inc. (US) | 2020-08-12 | — | — | EP | disclosed |
| EP-3684376-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING | Avidity Biosciences, Inc. (US) | 2020-07-29 | — | — | EP | disclosed |
| WO-2020132584-A1 | ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND USES THEREOF | AVIDITY BIOSCIENCES, INC. (US) | 2020-06-25 | — | — | WO | disclosed |
| WO-2019136180-A2 | HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF | AVIDITY BIOSCIENCES LLC (US) | 2019-07-11 | — | — | WO | disclosed |
| WO-2019113393-A1 | COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY | AVIDITY BIOSCIENCES LLC (US) | 2019-06-13 | — | — | WO | disclosed |
| WO-2019071028-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | AVIDITY BIOSCIENCES LLC (US) | 2019-04-11 | — | — | WO | disclosed |
| WO-2019060775-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING | AVIDITY BIOSCIENCES LLC (US) | 2019-03-28 | — | — | WO | disclosed |
| EP-3436588-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | Avidity Biosciences LLC (US) | 2019-02-06 | — | — | EP | disclosed |
| WO-2017173408-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | AVIDITY BIOSCIENCES LLC (US) | 2017-10-05 | — | — | WO | disclosed |
| EP-2585113-A1 | OPTIMIZED IN VIVO DELIVERY SYSTEM WITH ENDOSOMOLYTIC AGENTS FOR NUCLEIC ACID CONJUGATES | DNA Therapeutics (FR) | 2013-05-01 | — | — | EP | disclosed |
| WO-2012163814-A1 | CANCER TREATMENT BY COMBINING DNA MOLECULES MIMICKING DOUBLE STRAND BREAKS WITH HYPERTHERMIA | INSTITUT CURIE (FR) | 2012-12-06 | — | — | WO | disclosed |
| WO-2011161075-A1 | OPTIMIZED IN VIVO DELIVERY SYSTEM WITH ENDOSOMOLYTIC AGENTS FOR NUCLEIC ACID CONJUGATES | DNA THERAPEUTICS (FR) | 2011-12-29 | — | — | WO | disclosed |